Article
Ridgefield, CT—Eschenbach Optik of America Inc. is changing its senior management team with the promotion of its ophthalmic division president to company president.
Tenpoint Therapeutics and Visus Therapeutics complete merger, combining ophthalmic therapeutics portfolios
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Enhancing precision in GA imaging
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
Updates on EXG102 and EXG202 for wet AMD from Exegenesis Bio
Study: Fluoxetine improves visual acuity in adults with amblyopia